Another study of obese class III adolescents aged 12–17 years in the United States showed that prevalence of 7.7% for hypertension, 6.2% for type 2 diabetes, 9.0% for elevated ALT, 35.2% for dyslipidemia, and 13.6% for obstructive sleep apnea23. This evidence concerns the gene GPT and metabolic syndrome.